Delivered-To: sometime5858@gmail.com
Received: by 10.31.157.2 with SMTP id g2csp107679vke;
        Tue, 8 Nov 2016 18:08:55 -0800 (PST)
X-Received: by 10.55.133.193 with SMTP id h184mr18288427qkd.64.1478657335535;
        Tue, 08 Nov 2016 18:08:55 -0800 (PST)
Return-Path: <L.Gonzales@nucleusnetwork.com.au>
Received: from mail1.bemta8.messagelabs.com (mail1.bemta8.messagelabs.com. [216.82.243.203])
        by mx.google.com with ESMTPS id a134si21901249qkb.306.2016.11.08.18.08.37
        (version=TLS1_2 cipher=ECDHE-RSA-AES128-GCM-SHA256 bits=128/128);
        Tue, 08 Nov 2016 18:08:55 -0800 (PST)
Received-SPF: neutral (google.com: 216.82.243.203 is neither permitted nor denied by best guess record for domain of l.gonzales@nucleusnetwork.com.au) client-ip=216.82.243.203;
Authentication-Results: mx.google.com;
       spf=neutral (google.com: 216.82.243.203 is neither permitted nor denied by best guess record for domain of l.gonzales@nucleusnetwork.com.au) smtp.mailfrom=L.Gonzales@nucleusnetwork.com.au
Return-Path: <L.Gonzales@nucleusnetwork.com.au>
Received: from [216.82.242.131] by server-11.bemta-8.messagelabs.com id 12/ED-05157-88082285; Wed, 09 Nov 2016 01:48:56 +0000
X-Brightmail-Tracker: H4sIAAAAAAAAA2WUe0yTVxjGOd+1OLp9cglnZCTazcwhZaL/vJk
  sMy5xn4tzmEVDzCYrs6NNoJAWF+SP0QERYdwGiHITGK4CbkAAuYmAMAaUMuTmYApyLRcpuAoM
  GJe1FhiL/z15n+f3nPc7yXcEpG2ZtZNAGhwkVSokfiJmF3Xg79ACcYRa5HXwajwLccsNFIxkL
  5AwNrXKQqMxjoL7i85QteQFs+kpNLTczCRgbk1DQ1ltDQm/DTxm4U76Cgu/d2zQMFnaRcNa/S
  MaZpfGKdCEzyCIqKtj4W5+IQ3zsdMEaHNiSGhtyiGhMjWBgLzBZBqudRlN2MowA0lXr5Dw0xA
  Pjf2ZCBbz2xDM5Jcz0NqwTkLqbRPa09FLQPztWAq6+8MpKJ5tISBmoZ6E9cwJFrSFBQxkdRyB
  zonrBKSsPqQgf+AXGorTOmlIXmtn4PKUGDRRPQwkNuYxUBQ+SMDw9X4EfSNGBDcNOQTU9CZSU
  Fl9i4SqLBNV0mm6A33UPAGtKSdAb5xl4Y9pDQPFiVoSpn7wBnX38aPzJN8/rqf4mbwSlk/I3S
  D4iefZBF9a/IzhI56OMPyDsgqafzhXzfJhke0kX5U2wPLP/jrP55bUMfx4QhLLX/7ZgPjRGB3
  D/9jRRHl6nKPlCp+A4C9p2VB8PRXYqieCjSnztBo1tRPRaJfAlotDOEn3GEUjgYDhAK9lq6KR
  tcCO+wQnZVwhzdqe+wwnTreR5og9dxwbphzNY4p7C1ffH6HMWsidwkVPwllL5XUC3+jNYM2GN
  fcpXp6tJcwacc74nwePXnSSnCP+cyzrxRxz9ni4s42xaAc8NbpOW7QIh40akbmU5KIQ/q6wlr
  Wcthu3po5RCYhL29GVtjOXtiNnCSmwVnNtU7vi7LtGxqIPYE3OU3JL6+pHiZfnrji1qm+T3Yu
  bm3o3M7kI9628kma6GHOmu8htK5L8/TBr0WKceE9Nb831dzS0ZU8TOjOfTWz1627NMS/Drjhh
  fHAbLq6JZ7fhiiHd9sdkGO6RO+Fs5FiA9qukym+kSvEhdzcfpdxXFuQvkfuJ3Q+Cm79UpZL4S
  v0kPiq3rwL8S5DpDw61skKVqKrjowb0uoAQOQgNR0Vetq/6BFy4JJOoZN7Ki35SVQN6QyAQYa
  HxW5O3Wyn1lQZ/LfczPQNbNhbYiOyFDqEmW6gKlPir5L4WS4vEgkLD5BBhSykCFFInR+GAuYM
  zh2QXFdsVW49JF3J2shMiKysrW5tAqdJfHvR/fxo5CpDITrhobrGRK4K2T5o2LUGYlgj5fI95
  iSDJf5aTGu39orRe59Lkce5GjH3kWfcWsUi67/2JMyHsqlNzx5ttp1fD1GePaPdbiy/0vKPuO
  zPAVWwkP7l0snFPeTTepzz9XuRKCkkaPj458tpUrOdhp6ql5vMpb3tH1R7rSf9QF7j2nFeHHJ
  qO9zBWJ5xY1XsuTKJ3XT6w0asDxsqPLdsWHv5VRKlkEncXUqmS/AsrvhiQRwUAAA==
X-Env-Sender: L.Gonzales@nucleusnetwork.com.au
X-Msg-Ref: server-16.tower-76.messagelabs.com!1478656123!73848731!4
X-Originating-IP: [43.247.127.170]
X-StarScan-Received:
X-StarScan-Version: 9.0.13; banners=nucleusnetwork.com.au,-,-
X-VirusChecked: Checked
Received: (qmail 588 invoked from network); 9 Nov 2016 01:48:51 -0000
Received: from 170.127.247.43.static.as24516.net (HELO PRNEX2010.nucleus.local) (43.247.127.170)
  by server-16.tower-76.messagelabs.com with DHE-RSA-AES256-SHA encrypted SMTP; 9 Nov 2016 01:48:51 -0000
Received: from PRNEX2010.nucleus.local ([::1]) by PRNEX2010.nucleus.local
 ([::1]) with mapi id 14.02.0318.004; Wed, 9 Nov 2016 12:48:41 +1100
From: Louise Gonzales <L.Gonzales@nucleusnetwork.com.au>
Subject: Durect C928-005 new study. Do you know anyone who may be interested?
Thread-Topic: Durect C928-005 new study. Do you know anyone who may be
 interested?
Thread-Index: AdI6JW+uN23BAAruR+i6+bizM/NNJwAAIYQwAAEe8dAAAAXuMAAALEXQ
Date: Wed, 9 Nov 2016 01:48:40 +0000
Message-ID: <FD776FCE5BFEC045840FAB11F4BAF354B6575BBF@PRNEX2010.nucleus.local>
References: <FD776FCE5BFEC045840FAB11F4BAF354B6575A64@PRNEX2010.nucleus.local>
 <1FCE659FCBA9C6419E1EDB80CC0AFE1ABB9F3F@PRNEX2010.nucleus.local>
 <FD776FCE5BFEC045840FAB11F4BAF354B6575ABA@PRNEX2010.nucleus.local>
 <FD776FCE5BFEC045840FAB11F4BAF354B6575ACE@PRNEX2010.nucleus.local>
In-Reply-To: <FD776FCE5BFEC045840FAB11F4BAF354B6575ACE@PRNEX2010.nucleus.local>
Accept-Language: en-AU, en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator:
x-originating-ip: [192.168.101.57]
Content-Type: multipart/related;
	boundary="_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_";
	type="multipart/alternative"
MIME-Version: 1.0
X-TUID: FOegahwGyPAh

--_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: multipart/alternative;
	boundary="_000_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_"

--_000_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Follow us on Facebook and Instagram and check out our video on YouTube

[cid:image001.png@01D239C1.F266F230]<https://www.facebook.com/CfCStudies/>=
  [instagram] <https://www.instagram.com/centreforclinicalstudies/>   [cid=
:image003.png@01D239C1.F266F230] <https://www.youtube.com/watch?v=3DVp2x-P=
reRYU&feature=3Dyoutu.be>


Hello,



We have a new study for non-alcoholic fatty liver disease. We are looking =
for people aged between 36-56 years and have a BMI of 20.6-34.3. Please no=
te that only females of non-child bearing potential can participate (can't=
 physically have children even if they wanted to e.g. post-menopausal or s=
urgically sterile).



If you know anyone who could help or if you fit the bill, please see the c=
ontact details below.



If you are interested in the study below, please call us on

1800 243 733

or respond to this email.

We will call you and if appropriate book you in for a screening visit (med=
ical check up).



Please note we call from a private number.



C928-005: Fat build up in the liver=20is responsible for liver disease whi=
ch affects between 9% and 37% of the population in different parts of the =
world. Non-alcoholic fatty liver disease (NAFLD) is becoming an increasing=
 problem in Australia in parallel with the growing obesity epidemic. If le=
ft untreated, NAFLD can lead to other liver diseases such as cirrhosis (sc=
ar tissue in the liver leading to impaired function), Nonalcoholic Steatoh=
epatitis (NASH) (the more severe form of NAFLD), cancer or complete liver =
failure. More recently NAFLD has been associated with kidney disease even =
in the absence of obesity. Therefore, not only is it important that a trea=
tment for NAFLD can be used in patients with kidney disease, but it is pos=
sible that one drug could treat both diseases.
DUR-928 may work by improving the way the body breaks down fats so that th=
ey can be eliminated from the body and not build up in the liver to cause =
NAFLD. To date, DUR-928 has been given to a total of 50 healthy participan=
ts as an oral solution as a single dose up to 1000 mg (30 people) and mult=
iple doses up to 300 mg per day for 5 days (20 people). In addition, DUR-9=
28 has also been given as injection into the buttock as a single dose up t=
o 300 mg (24 people) and in multiple doses up to 150 mg per day for 5 days=
 (10 people).

In animal studies of chronic kidney disease (CKD), DUR-928 has also shown =
some potential for use in CKD patients. Therefore, this study will study t=
he effect of a single dose of DUR-928 when administered as a single inject=
ion into the buttock up to 120 mg in patients with stage 3 and stage 4 kid=
ney disease, as compared to the effects in a healthy volunteer population =
matched to the CKD patients by average age, Body Mass Index (BMI - a ratio=
 of your weight to height) and gender ratio.


Volunteers required:

*         Healthy men

*         Healthy women who are not physiologically capable of having chil=
dren as they are post menopausal or surgically sterile via hysterectomy, o=
opherectomy or bilateral tubal ligation.

*         Aged 36 - 56 years

*      =20  BMI 20.6 - 34.3  Link to BMI calculator:  http://halls.md/body=
-mass-index/av.htm

*         Not taking any medications (stable thyroid medications are ok)


Study Duration

*          3 days/ 4 nights as an inpatient

*          2 outpatient visits


Our Location

Centre for Clinical Studies (AMREP Precinct Alfred Hospital) AMREP access =
map<http://clinicalstudies.com.au/wp-content/uploads/2014/02/AMREP-CCS-Acc=
ess-MAP.pdf>
Level 5, 89 Commercial Road,
Melbourne, 3004.
Click here<https://maps.google.com.au/maps?q=3D89+commercial+road+melbourn=
e+3004&ie=3DUTF-8&hq=3D&hnear=3D0x6ad66822902afed9:0xca1cf794638a5956,85-8=
9+Commercial+Rd,+Melbourne+VIC+3004&gl=3Dau&ei=3DrwD8UqTNL4GRkwX88YH4Aw&ve=
d=3D0CCYQ8gEwAA> for the Google map.

Reimbursement: $1,050

Study Schedule:
Study Day

Date

Time

Comments

In-Patient Stay

* Day - 1 (admission)

Monday, 21 November 2016

~2pm

Check-In

Day 3

Thursday, 24 November 2016

morning

Discharge (am)

Outpatient visits

* Day 4

Friday, 25 November 2016

~1hr

Outpatient

* Day 7 - 10

Wednesday, 30 November 2016

~1hr

Outpatient


To view our Participant Information Brochure please click here<http://clin=
icalstudies.com.au/wp-content/uploads/2014/02/CCS-Volunteer-Brochure.pdf> =
and read more about our organisation and about clinical trials generally.

Please also visit our website atwww.clinicalstudies.com.au<http://www.clin=
icalstudies.com.au>

If you do not wish to receive any further emails from us then please reply=
 to this email with the word 'unsubscribe' in the subject box.


Thanking you again for your interest.

Warm Regards,
Louise

Louise Gonzales| Senior Recruitment Officer | Centre for Clinical Studies =
|
Office| Level 5 Burnet Institute, AMREP Precinct | 89 Commercial Road Melb=
ourne Victoria 3004, Australia |
T  61 3 9076 9019 | F 61 3 9076 8940 | E l.gonzales@nucleusnetwork.com.au<=
mailto:l.gonzales@nucleusnetwork.com.au> |
1800 243 733

www.clinicalstudies.com<http://www.nucleusnetwork.com.au/>.au<http://www.n=
ucleusnetwork.com.au/>
Nucleus Network, Australia's Clinical Research Centre, operates in associa=
tion with Centre for Clinical Studies,
Clinical Trials Consulting and its network partners
P  Please consider the environment before printing this e-mail





______________________________________________________________________
This email has been scanned by the Symantec Email Security.cloud service.
For more information please visit http://www.symanteccloud.com
______________________________________________________________________
--_000_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-mic=
rosoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word=
" xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"ht=
tp://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii=
">
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
=09{font-family:"Cambria Math";
=09panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
=09{font-family:Calibri;
=09panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
=09{font-family:Consolas;
=09panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
=09{font-family:Webdings;
=09panose-1:5 3 1 2 1 5 9 6 7 3;}
@font-face
=09{font-family:Verdana;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
=09{margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
=09{mso-style-priority:99;
=09color:blue;
=09text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
=09{mso-style-priority:99;
=09color:purple;
=09text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
=09{mso-style-priority:99;
=09mso-style-link:"Plain Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:10.5pt;
=09font-family:Consolas;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
=09{mso-style-priority:34;
=09margin-top:0cm;
=09margin-right:0cm;
=09margin-bottom:0cm;
=09margin-left:36.0pt;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri",sans-serif;}
p.msonormal0, li.msonormal0, div.msonormal0
=09{mso-style-name:msonormal;
=09mso-margin-top-alt:auto;
=09margin-right:0cm;
=09mso-margin-bottom-alt:auto;
=09margin-left:0cm;
=09font-size:12.0pt;
=09font-family:"Times New Roman",serif;}
span.PlainTextChar
=09{mso-style-name:"Plain Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Plain Text";
=09font-family:Consolas;}
p.Default, li.Default, div.Default
=09{mso-style-name:Default;
=09margin:0cm;
=09margin-bottom:.0001pt;
=09text-autospace:none;
=09font-size:12.0pt;
=09font-family:"Verdana",sans-serif;
=09color:black;}
span.EmailStyle22
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle23
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle24
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle25
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle26
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle27
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle28
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle29
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle30
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle31
=09{mso-style-type:personal;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
span.EmailStyle32
=09{mso-style-type:personal-reply;
=09font-family:"Calibri",sans-serif;
=09color:windowtext;}
.MsoChpDefault
=09{mso-style-type:export-only;
=09font-size:10.0pt;}
@page WordSection1
=09{size:612.0pt 792.0pt;
=09margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
=09{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-AU" link=3D"blue" vlink=3D"purple">
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><span style=3D"font-size:10.0pt">F<span style=3D"co=
lor:#285EA0">ollow us on Facebook and Instagram and check out our video on=
 YouTube</span></span><span style=3D"font-size:9.0pt;color:#285EA0"><o:p><=
/o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:2.0pt"><o:p>&nbsp;</o:p></=
span></p>
<p class=3D"MsoNormal"><a href=3D"https://www.facebook.com/CfCStudies/"><s=
pan style=3D"color:#1F497D;text-decoration:none"><img border=3D"0" width=3D=
"29" height=3D"29" style=3D"width:.302in;height:.302in" id=3D"Picture_x002=
0_3" src=3D"cid:image002.png@01D23A83.0F20A490" alt=3D"cid:image001.png@01=
D239C1.F266F230"></span></a>&nbsp;&nbsp;<a href=3D"https://www.instagram.c=
om/centreforclinicalstudies/"><span style=3D"color:windowtext;text-decorat=
ion:none"><img border=3D"0" width=3D"29" height=3D"29" style=3D"width:.302=
in;height:.302in" id=3D"_x0000_i1026" src=3D"cid:image003.jpg@01D23A83.0F2=
0A490" alt=3D"instagram"></span></a>
 &nbsp;<a href=3D"https://www.youtube.com/watch?v=3DVp2x-PreRYU&amp;featur=
e=3Dyoutu.be"><span style=3D"color:#1F497D;text-decoration:none"><img bord=
er=3D"0" width=3D"74" height=3D"30" style=3D"width:.7708in;height:.3125in"=
 id=3D"Picture_x0020_4" src=3D"cid:image004.png@01D23A83.0F20A490" alt=3D"=
cid:image003.png@01D239C1.F266F230"></span></a><o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">Hello,</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif">We have a new study for non-alcoholic fatty li=
ver disease. We are looking for people aged between 36-56 years and have a=
 BMI of 20.6-34.3. Please note that only females
 of non-child bearing potential can participate (can&#8217;t physically ha=
ve children even if they wanted to e.g. post-menopausal or surgically ster=
ile).<o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif">If you know anyone who could help or if you fi=
t the bill, please see the contact details below.
<o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif=
;color:#6600FF">If you are interested in the study below, please call us o=
n</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sa=
ns-serif"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<b><span style=3D"font-size:22.0pt;font-family:&quot;Calibri&quot;,sans-se=
rif">1800 243 733</span></b><span style=3D"font-size:18.0pt;font-family:&q=
uot;Calibri&quot;,sans-serif">
<o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif=
;color:#6600FF">or respond to this email.
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif=
;color:#6600FF">We will call you and if appropriate book you in for a scre=
ening visit (medical check up).</span><span style=3D"color:black"><o:p></o=
:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><sp=
an style=3D"font-size:5.0pt;font-family:&quot;Calibri&quot;,sans-serif"><o=
:p>&nbsp;</o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-se=
rif">Please note we call from a
<u>private number.</u></span><o:p></o:p></b></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:#6600FF">&nbsp;</span><span style=3D"colo=
r:black"><o:p></o:p></span></p>
<p class=3D"Default"><b><span style=3D"font-size:11.0pt;font-family:&quot;=
Calibri&quot;,sans-serif;color:windowtext">C928-005:</span></b><span style=
=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;color:wind=
owtext">&nbsp;</span><span style=3D"font-size:11.0pt;font-family:&quot;Cal=
ibri&quot;,sans-serif">Fat
 build up in the liver is responsible for liver disease which affects betw=
een 9% and 37% of the population in different parts of the world. Non-alco=
holic fatty liver disease (NAFLD) is becoming an increasing problem in Aus=
tralia in parallel with the growing
 obesity epidemic. If left untreated, NAFLD can lead to other liver diseas=
es such as cirrhosis (scar tissue in the liver leading to impaired functio=
n), Nonalcoholic Steatohepatitis (NASH) (the more severe form of NAFLD), c=
ancer or complete liver failure. More
 recently NAFLD has been associated with kidney disease even in the absenc=
e of obesity. Therefore, not only is it important that a treatment for NAF=
LD can be used in patients with kidney disease, but it is possible that on=
e drug could treat both diseases.
</span><span style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><span style=3D"color:=
black">DUR-928 may work by improving the way the body breaks down fats so =
that they can be eliminated from the body and not build up in the liver to=
 cause NAFLD. To date, DUR-928 has been given
 to a total of 50 healthy participants as an oral solution as a single dos=
e up to 1000 mg (30 people) and multiple doses up to 300 mg per day for 5 =
days (20 people). In addition, DUR-928 has also been given as injection in=
to the buttock as a single dose up
 to 300 mg (24 people) and in multiple doses up to 150 mg per day for 5 da=
ys (10 people).
<o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">In animal studies of chronic kidne=
y disease (CKD), DUR-928 has also shown some potential for use in CKD pati=
ents. Therefore, this study will study the effect
 of a single dose of DUR-928 when administered as a single injection into =
the buttock up to 120 mg in patients with stage 3 and stage 4 kidney disea=
se, as compared to the effects in a healthy volunteer population matched t=
o the CKD patients by average age,
 Body Mass Index (BMI &#8211; a ratio of your weight to height) and gender=
 ratio.</span><span style=3D"font-size:11.0pt;color:black"><o:p></o:p></sp=
an></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Volunteers required:=
 </span></b><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"color:black">&middot;</span><span style=3D"font-size:7.0pt;font-family:&q=
uot;Times New Roman&quot;,serif;color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Healthy men<o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"color:black">&middot;</span><span style=3D"font-size:7.0pt;font-family:&q=
uot;Times New Roman&quot;,serif;color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Healthy women </span><span style=3D"col=
or:#6600FF">who are
<u>not</u> physiologically capable of having children as they are post men=
opausal or surgically sterile via hysterectomy, oopherectomy or bilateral =
tubal ligation.</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"color:black">&middot;</span><span style=3D"font-size:7.0pt;font-family:&q=
uot;Times New Roman&quot;,serif;color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;
</span><b><span style=3D"color:black">Aged 36 &#8211; 56 years </span></b>=
<span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"color:black">&middot;</span><span style=3D"font-size:7.0pt;font-family:&q=
uot;Times New Roman&quot;,serif;color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;
</span><b><span style=3D"color:black">BMI 20.6 &#8211; 34.3&nbsp; </span><=
/b>Link to BMI calculator: &nbsp;<span style=3D"color:#C00000"><a href=3D"=
http://halls.md/body-mass-index/av.htm">http://halls.md/body-mass-index/av=
.htm</a></span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt"><span style=3D=
"color:black">&middot;</span><span style=3D"font-size:7.0pt;font-family:&q=
uot;Times New Roman&quot;,serif;color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;
</span><span style=3D"color:black">Not taking any medications </span>(stab=
le thyroid medications are ok)<span style=3D"color:black"><o:p></o:p></spa=
n></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D">&nbsp;</span><span st=
yle=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,sans-serif;color:black">Study Duration</span></b><span =
style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt"=
><span style=3D"font-size:11.0pt;color:black">&middot;</span><span style=3D=
"font-size:7.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black=
">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif;color:black">&nbsp;3 days/ 4 nights as an inpatient
</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt"=
><span style=3D"font-size:11.0pt;color:black">&middot;</span><span style=3D=
"font-size:7.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black=
">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,san=
s-serif;color:black">&nbsp;2 outpatient visits</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">&nbsp;</span><span style=3D"color:=
black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Our Location</span><=
/b><span style=3D"color:black">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><o:p><=
/o:p></p>
<p class=3D"MsoNormal"><span style=3D"font-size:4.0pt"><o:p>&nbsp;</o:p></=
span></p>
<p class=3D"MsoNormal" style=3D"margin-left:19.85pt"><span style=3D"color:=
black">Centre for Clinical Studies
</span><span lang=3D"EN-US" style=3D"color:black">(AMREP Precinct Alfred H=
ospital) </span>
<span style=3D"color:black"><a href=3D"http://clinicalstudies.com.au/wp-co=
ntent/uploads/2014/02/AMREP-CCS-Access-MAP.pdf"><span style=3D"color:windo=
wtext">AMREP access map</span></a><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:19.85pt"><span lang=3D"EN-US" =
style=3D"color:black">Level 5, 89 Commercial Road,
</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:19.85pt"><span lang=3D"EN-US" =
style=3D"color:black">Melbourne, 3004</span><span style=3D"color:black">.<=
o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-left:19.85pt"><span style=3D"color:=
black">Click <a href=3D"https://maps.google.com.au/maps?q=3D89&#43;commerc=
ial&#43;road&#43;melbourne&#43;3004&amp;ie=3DUTF-8&amp;hq=3D&amp;hnear=3D0=
x6ad66822902afed9:0xca1cf794638a5956,85-89&#43;Commercial&#43;Rd,&#43;Melb=
ourne&#43;VIC&#43;3004&amp;gl=3Dau&amp;ei=3DrwD8UqTNL4GRkwX88YH4Aw&amp;ved=
=3D0CCYQ8gEwAA">
<span style=3D"color:windowtext">here</span></a> for the <b>Google map</b>=
.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">&nbsp;</span></b><sp=
an style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Reimbursement</span>=
</b><span style=3D"color:black">:
</span><b><span style=3D"font-size:16.0pt;color:#6600FF">$1,050</span></b>=
<span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:black">Study Schedule:</spa=
n></b><span style=3D"color:black"><o:p></o:p></span></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" width=3D"645" style=3D"width:484.0pt;margin-left:.1pt;border-collap=
se:collapse">
<tbody>
<tr style=3D"height:15.75pt">
<td width=3D"245" nowrap=3D"" colspan=3D"2" style=3D"width:183.8pt;border:=
solid white 1.0pt;border-bottom:solid white 3.0pt;background:#360086;paddi=
ng:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:white">Study Day</span></b><o:p></o:p></p>
</td>
<td width=3D"208" nowrap=3D"" style=3D"width:155.9pt;border-top:solid whit=
e 1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:soli=
d white 1.0pt;background:#360086;padding:0cm 5.4pt 0cm 5.4pt;height:15.75p=
t">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:white">Date</span></b><o:p></o:p></p>
</td>
<td width=3D"78" nowrap=3D"" style=3D"width:58.3pt;border-top:solid white =
1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:solid =
white 1.0pt;background:#360086;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt"=
>
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:white">Time</span></b><o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:solid white=
 1.0pt;border-left:none;border-bottom:solid white 3.0pt;border-right:solid=
 white 1.0pt;background:#360086;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt=
">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:white">Comments</span></b><o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"92" nowrap=3D"" rowspan=3D"2" style=3D"width:68.85pt;border-t=
op:none;border-left:solid white 1.0pt;border-bottom:solid white 3.0pt;bord=
er-right:solid white 1.0pt;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">In-Pat=
ient Stay<o:p></o:p></p>
</td>
<td width=3D"153" nowrap=3D"" style=3D"width:114.95pt;border-top:none;bord=
er-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0p=
t;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">* Day =
- 1 (admission)<o:p></o:p></p>
</td>
<td width=3D"208" nowrap=3D"" style=3D"width:155.9pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Monday=
, 21 November 2016<o:p></o:p></p>
</td>
<td width=3D"78" nowrap=3D"" style=3D"width:58.3pt;border-top:none;border-=
left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;b=
ackground:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">~2pm<o=
:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Check-=
In<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.75pt">
<td width=3D"153" nowrap=3D"" style=3D"width:114.95pt;border-top:none;bord=
er-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0p=
t;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 3<=
o:p></o:p></p>
</td>
<td width=3D"208" nowrap=3D"" style=3D"width:155.9pt;border-top:none;borde=
r-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt=
;background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Thursd=
ay, 24 November 2016<o:p></o:p></p>
</td>
<td style=3D"border-top:none;border-left:none;border-bottom:solid white 3.=
0pt;border-right:solid white 1.0pt;background:#FBD4B4;padding:0cm 0cm 0cm =
0cm;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">mornin=
g<o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 3.0pt;border-right:solid white 1.0pt;=
background:#FBD4B4;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Discha=
rge (am)<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.75pt">
<td width=3D"92" rowspan=3D"2" style=3D"width:68.85pt;border:solid white 1=
.0pt;border-top:none;background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height=
:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient visits<o:p></o:p></p>
</td>
<td width=3D"153" nowrap=3D"" style=3D"width:114.95pt;border-top:none;bord=
er-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0p=
t;background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">* Day =
4<o:p></o:p></p>
</td>
<td width=3D"208" nowrap=3D"" style=3D"width:155.9pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Friday=
, 25 November 2016<o:p></o:p></p>
</td>
<td width=3D"78" nowrap=3D"" style=3D"width:58.3pt;border-top:none;border-=
left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;b=
ackground:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">~1hr<o=
:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"153" nowrap=3D"" style=3D"width:114.95pt;border-top:none;bord=
er-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0p=
t;background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">* Day =
7 - 10<o:p></o:p></p>
</td>
<td width=3D"208" nowrap=3D"" style=3D"width:155.9pt;border-top:none;borde=
r-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt=
;background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Wednes=
day, 30 November 2016<o:p></o:p></p>
</td>
<td width=3D"78" nowrap=3D"" style=3D"width:58.3pt;border-top:none;border-=
left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;b=
ackground:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">~1hr<o=
:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid white 1.0pt;border-right:solid white 1.0pt;=
background:#EAF1DD;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">To view our Participant=
 Information Brochure please
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2014/02/CCS-Vo=
lunteer-Brochure.pdf">
click here</a> and read more about our organisation and about clinical tri=
als generally.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:red">&nbsp;</span><span style=3D=
"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">Please also visit our w=
ebsite at</span><span style=3D"color:#1F497D"><a href=3D"http://www.clinic=
alstudies.com.au">www.clinicalstudies.com.au</a>
</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#C00000">If you do not wish=
 to receive any further emails from us then please reply to this email wit=
h the word &#8216;unsubscribe&#8217; in the subject box.</span></b><span s=
tyle=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">&nbsp;<o:p></o:p></span=
></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,sans-serif;color:black">Thanking you again for your intere=
st.</span><span style=3D"color:black"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:black">&nbsp;</span><o:p></o:p=
></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D">Warm Regards,<o:p></o=
:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D">Louise<o:p></o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;color:#8DB3E2">L=
ouise Gonzales</span></b><b><span style=3D"font-size:10.0pt;color:#1F497D"=
>|</span></b><span style=3D"font-size:10.0pt;color:#1F497D">&nbsp;<b>Senio=
r Recruitment Officer</b>
<b>|</b> </span><b><span style=3D"font-size:10.0pt;color:#00B0F0">Centre f=
or Clinical Studies</span></b><span style=3D"font-size:10.0pt;color:#99CC0=
0">
</span><b><span style=3D"font-size:10.0pt;color:#1F497D">|</span></b><span=
 style=3D"font-size:10.0pt;color:#1F497D">&nbsp;&nbsp;<br>
<b>Office|</b> Level 5 Burnet Institute, AMREP Precinct | 89 Commercial Ro=
ad Melbourne&nbsp;Victoria 3004, Australia
<b>|</b><br>
<b>T</b>&nbsp; 61 3 9076 9019 |&nbsp;<b>F</b> 61 3 9076 8940 |<b> E </b></=
span><a href=3D"mailto:l.gonzales@nucleusnetwork.com.au"><b><span style=3D=
"font-size:10.0pt;color:#00B0F0">l.gonzales@nucleusnetwork.com.au</span></=
b></a><span style=3D"font-size:10.0pt;color:#1F497D">
 | </span><span style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:20.0pt;color:#1F497D">1=
800 243 733<o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:4.0pt;color:#1F497D"><o=
:p>&nbsp;</o:p></span></b></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:12.0pt"><span=20style=3D"fon=
t-size:20.0pt;color:#002060"><a href=3D"http://www.nucleusnetwork.com.au/"=
><b><span style=3D"font-size:14.0pt;color:#002060">www.clinicalstudies.com=
</span></b></a><a href=3D"http://www.nucleusnetwork.com.au/"><b><span styl=
e=3D"font-size:14.0pt;color:#002060">.au</span></b></a></span><span style=3D=
"font-size:4.0pt;color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><i><span style=3D"=
font-size:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#1F497D">Nu=
cleus Network, Australia's Clinical Research Centre, operates in associati=
on with Centre for Clinical Studies,
<o:p></o:p></span></i></b></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><b><i><span style=3D"=
font-size:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#1F497D">Cl=
inical Trials Consulting and its network partners<o:p></o:p></span></i></b=
></p>
<p class=3D"MsoNormal" style=3D"text-autospace:none"><span style=3D"font-s=
ize:18.0pt;font-family:Webdings;color:green">P</span><span style=3D"font-s=
ize:8.0pt;font-family:&quot;Arial&quot;,sans-serif;color:green">&nbsp;
<b><i>Please consider the environment before printing this e-mail</i></b><=
/span><b><i><span style=3D"font-size:8.0pt;font-family:&quot;Arial&quot;,s=
ans-serif;color:#1F497D"><o:p></o:p></span></i></b></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><b><i><span style=3D"font-size:8.0pt;font-family:&q=
uot;Arial&quot;,sans-serif;color:#1F497D"><o:p>&nbsp;</o:p></span></i></b>=
</p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:black"><o:p>&nbsp;</o:p></span=
></p>
</div>
<br clear=3D"both">
______________________________________________________________________<BR>=

This email has been scanned by the Symantec Email Security.cloud service.<=
BR>
For more information please visit http://www.symanteccloud.com<BR>
______________________________________________________________________<BR>=

</body>
</html>

--_000_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_--

--_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: image/png; name="image002.png"
Content-Description: image002.png
Content-Disposition: inline; filename="image002.png"; size=1102;
	creation-date="Wed, 09 Nov 2016 01:16:13 GMT";
	modification-date="Wed, 09 Nov 2016 01:16:13 GMT"
Content-ID: <image002.png@01D23A83.0F20A490>
Content-Transfer-Encoding: base64
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--_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: image/jpeg; name="image003.jpg"
Content-Description: image003.jpg
Content-Disposition: inline; filename="image003.jpg"; size=1003;
	creation-date="Wed, 09 Nov 2016 01:16:13 GMT";
	modification-date="Wed, 09 Nov 2016 01:16:13 GMT"
Content-ID: <image003.jpg@01D23A83.0F20A490>
Content-Transfer-Encoding: base64
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--_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_
Content-Type: image/png; name="image004.png"
Content-Description: image004.png
Content-Disposition: inline; filename="image004.png"; size=4620;
	creation-date="Wed, 09 Nov 2016 01:16:13 GMT";
	modification-date="Wed, 09 Nov 2016 01:16:13 GMT"
Content-ID: <image004.png@01D23A83.0F20A490>
Content-Transfer-Encoding: base64
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--_006_FD776FCE5BFEC045840FAB11F4BAF354B6575BBFPRNEX2010nucleu_--
